Cannabis Report
Home > Boards > US Listed > Biotechs >

Alliqua, Inc. (ALQA)

Add ALQA Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 5/9/2018 1:38:35 PM - Followers: 71 - Board type: Free - Posts Today: 0

Headquartered in New York, Alliqua, Inc., (OTCBB:ALQA) is a biomedical company focused on the development, manufacturing and marketing of its own proprietary products, utilizing its existing technology portfolio. It intends to pursue projects in the fields of active ingredient and transdermal drug delivery, as well as advanced wound care.


Alliqua's core transdermal delivery technology platform is designed to deliver drugs and other beneficial ingredients through the skin.  Transdermal delivery has multiple advantages over conventional oral and injection delivery including:

  • Avoidance of hepatic first pass metabolism causing less stress on the liver;
  • Non-invasive nature;
  • Improved patient compliance;
  • Discontinuation of administration by removal of the system;
  • Lower dosage;
  • No dependence on different metabolic rates of individuals; and
  • No interaction with the gastrointestinal system.

In addition, Alliqua's  patch technology can be utilized for the delivery of many drugs, including various proteins that have, until now, necessitated injections or intravenous infusions.

Alliqua intends to capitalize on its technology's other intrinsic benefits in various market verticals in the healthcare industry, including: wound healing, medical diagnostics and cosmeceuticals.






Alliqua, through its wholly owned subsidiary AquaMed, develops, manufactures and markets electron-beam cross-linked sheet gels for use as transdermal delivery of medication, topical application of non-prescription drugs, wound/burn dressings with and without active ingredients, components in certain medical devices, treatments, cosmetics and other commercial products.

Hydrogels are gel-like or colloidal substances made of water and solids.  They can be created chemically (through a combination of ultra violet cross-linking and chemical interface), or by mixing polymer and water, and then exposing it to an electron beam creating a "sheet" of water. Alliqua believes that its hydrogels have a competitive advantage, in part due to the following product characteristics: painless adhesion to the human body, stability of form and composition, purity, reproducibility (manufacturing high quality product on a consistent basis), compatibility with active ingredients, and high water content.

Many of the products of Alliqua's competition feature physical characteristics which Alliqua believes are less desirable than its own hydrogels

Investor relations

Alliqua Inc.
850 3rd Avenue
Suite 1801
New York, NY 10022



Subsidiary Products
Alliqua Biomedical PHN Patch
  Hydress + Plus
Aquamed Technologies Contract Manufacturing Services
  Electrode Gel
  Sheet Hydrogels
HepaLife Biosystems HepaMate®

Alliqua is currently servicing the medical components marketplace through it Aquamed Technologies, Inc. subsidiary. It is also developing finished products for commercialization under its own brand names. The following table lists the various product in commercialization and development:



Thursday, November 15, 2012

Wednesday, November 14, 2012

Tuesday, November 13, 2012

Wednesday, October 3, 2012

Wednesday, August 22, 2012

Thursday, August 16, 2012

Tuesday, August 14, 2012

Thursday, August 2, 2012

Tuesday, June 5, 2012

Thursday, May 24, 2012

CHARTS : 60 minutes - Daily - Weekly


Cannabis Report
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#4779   Can Erupt Soon...Low O/S Bio-Play zino 05/09/18 01:38:35 PM
#4778   well, the CFO is gone. Now bryce7517 03/20/18 06:30:20 PM
#4777   just waiting for a real business leader to bryce7517 03/19/18 07:52:34 PM
#4776   ALQA cheat sheet Golden_Cross 03/12/18 10:10:09 PM
#4775   Money flow into ALQI very high Golden_Cross 03/12/18 10:09:14 PM
#4774   Volume on alert today Golden_Cross 03/12/18 10:08:34 PM
#4773   Chart looking good Golden_Cross 03/12/18 10:08:01 PM
#4772   I took the time to read the report.... bryce7517 03/03/18 05:13:03 AM
#4771   well, when will the board clean house and bryce7517 02/18/18 05:22:13 AM
#4770   Well, guess 4 dollars did not happen. bryce7517 01/08/18 06:03:53 PM
#4769   Actually might hit $4 AH. INTL 01/05/18 04:56:26 PM
#4768   once this breaks below 2 bucks... look out bryce7517 12/13/17 08:02:44 PM
#4767   ooops, heading further south. Once this bryce7517 12/05/17 12:19:07 PM
#4766   and a real CEO bryce7517 11/28/17 01:32:51 PM
#4765   agree. but, current mis-management is to arrogant bryce7517 11/25/17 07:57:35 PM
#4764   a new sales team for starters proffetti 11/25/17 07:54:38 PM
#4763   I have been saying all along, NEW CEO, bryce7517 11/25/17 03:51:22 AM
#4762   ALQA a chain of very painful events. ouch proffetti 11/24/17 07:13:50 PM
#4761   it does not "have the ingredients". bryce7517 11/16/17 04:45:20 AM
#4760   Low Float stocks been flying...this has the ingredients zino 11/15/17 07:14:29 PM
#4759   That is what makes a market. You bryce7517 11/15/17 04:42:53 PM
#4758   2.47 HOD...More tomorrow imo zino 11/15/17 04:00:51 PM
#4757   Touched 2.4O zino 11/15/17 03:27:37 PM
#4756 yer plan..I'll do mine zino 11/15/17 03:08:00 PM
#4755   Bought Shares At 2.13 zino 11/15/17 03:06:42 PM
#4754   yes it is, but, we have no idea bryce7517 11/15/17 02:40:10 PM
#4753   Super Low O/S Bio-Play zino 11/15/17 02:27:14 PM
#4752   O/S is Just 5 Million zino 11/15/17 01:11:17 PM
#4751   I am surprised it is still above 2 bryce7517 11/14/17 05:22:13 AM
#4750   please respond with share structure TIA proffetti 10/24/17 02:47:58 PM
#4749   I would think melt down. You bryce7517 10/23/17 03:49:17 PM
#4748   Eruption Soon zino 10/20/17 09:43:29 AM
#4747   New Low floater...has big upside in todays bio-market zino 10/19/17 03:37:52 PM
#4746   Wait for the shorts to do their job bryce7517 10/07/17 04:52:47 AM
#4745   buying now would be dangerous, IMHO. They bryce7517 10/07/17 04:49:56 AM
#4744   buyers are back..... could see a nice move Maxgambit 10/06/17 10:38:39 AM
#4743   buyers are back..... could see a nice move Maxgambit 10/06/17 10:38:38 AM
#4742   Finally. We need to get that cloud bryce7517 10/06/17 05:36:15 AM
#4741   Alliqua BioMedical, Inc. Announces 1-for-10 Reverse Stock Split nbm16yankees 10/05/17 04:23:06 PM
#4740   Is it just me, but on the day bryce7517 09/29/17 05:30:38 AM
#4739   $ALQA volume was 461,534 Bunti 09/22/17 10:03:31 AM
#4738   I agree with you ABOUT. This bryce7517 09/22/17 06:12:39 AM
#4737   This is rocking. About to break HOD Barry Allen 09/21/17 03:25:56 PM
#4736   CELGENE CORPORATION Owns 18.8% Of Company zino 09/21/17 09:45:20 AM
#4735   Celgene Buying in ...I'm Buying zino 09/21/17 09:34:04 AM
#4734   this company has great products, but terrible management. bryce7517 09/16/17 09:07:29 AM
#4733   what a trap!:/ juancarlos 09/14/17 01:31:09 PM
#4732   So, here it is in writing. They bryce7517 09/14/17 05:53:43 AM
#4731   I am also anxious to hear about the bryce7517 09/13/17 07:27:47 PM
#4730   09-13-17 Shareholder meeting news? Did they release any Tyrant Tommy 09/13/17 11:20:08 AM